CompletedNCT00310791
Hormone therapy and bone health in young women with anorexia
About this title
Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Read the official source — NCT00310791Medication studyAges 15–30United StatesEating disorders
Understand this study
Who was this study for?
Listed age limits: 15 years to 30 years.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateApril 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 80
- Sponsor
- Boston Children's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 15 Years to 30 Years
- Official registry ID
- NCT00310791
- Official title
Show the full official title
Effects of Adrenal and Gonadal Hormone Replacement in Young Women With Anorexia Nervosa
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedBoston
Questions about this study
Who is behind this study?
The study sponsor is Boston Children's Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Dehydroepiandrosterone (DHEA).
Who was this study for?
Listed age limits: 15 years to 30 years.
